Hot flushes treatment while giving Egolix
Reading File
Finding Sources
Searching PubMed
elagolix AND vasomotor symptoms
Searching the Web
elagolix prescribing information hot flushes management add-back therapy
Assuming “Egolix” means elagolix: hot flushes/night sweats are common because it lowers estrogen levels. They are dose-related and can also signal greater bone-loss risk.
What to do
- Do not start estrogen or “add-back” therapy on your own. It needs the prescriber to balance symptom relief against endometriosis/fibroid control, contraception needs, clotting risk, and bone health.
- Start with practical measures: layered clothing, fan/cool bedroom, avoid alcohol, smoking, spicy foods and hot drinks, and consider sleep/stress management.
- If troublesome, contact the gynecologist to consider:
- Lowering the elagolix dose or stopping it, if clinically appropriate.
- Changing treatment. For fibroids, a fixed-dose GnRH-antagonist regimen with add-back hormones may be considered. For endometriosis, add-back with elagolix alone is not routinely self-managed and may be off-label depending on location/product.
- A non-hormonal hot-flush treatment when appropriate, such as an SSRI/SNRI, gabapentin, or another option chosen after reviewing your other medicines and medical history.
Tell the prescriber promptly if flushes are severe, persistent, affecting sleep/function, or occur with low mood, anxiety, bone pain/fracture, or possible pregnancy. Elagolix can cause bone mineral density loss and is contraindicated in pregnancy and known osteoporosis. Hot flushes are listed as a common adverse effect in the Orilissa safety information; clinical trials also found higher hot-flush rates and greater bone-density decline than placebo (Berek & Novak's Gynecology, p. 143).
Please confirm: is she receiving elagolix for endometriosis or fibroids, and what dose/product is being used?
This is a shared conversation. Sign in to Orris to start your own chat.